Glycosaminoglycans and semisynthetic sulfated polysaccharides: an overview of their potential application in treatment of patients with urolithiasis.

[1]  F. Schröder,et al.  Does urinary oxalate interfere with the inhibitory role of glycosaminoglycans and semisynthetic sulfated polysaccharides in calcium oxalate crystallization? , 1997, European urology.

[2]  R. Ryall,et al.  The effect of heparan sulphate on the crystallization of calcium oxalate in undiluted, ultrafiltered human urine. , 1996, British journal of urology.

[3]  F. Schröder,et al.  Crystal-cell interaction inhibition by polysaccharides. , 1996, The Journal of urology.

[4]  F. Schröder,et al.  Zeta potential measurement and particle size analysis for a better understanding of urinary inhibitors of calcium oxalate crystallization. , 1996, Scanning microscopy.

[5]  F. Schröder,et al.  Effect of two new polysaccharides on growth, agglomeration and zeta potential of calcium phosphate crystals. , 1996, The Journal of urology.

[6]  F. Schröder,et al.  Association of calcium oxalate monohydrate crystals with MDCK cells. , 1995, Kidney international.

[7]  J. Lieske,et al.  Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. , 1995, The American journal of physiology.

[8]  R. D. de Water,et al.  Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation. , 1995, Scanning microscopy.

[9]  F. Schröder,et al.  Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? , 1995, Scanning microscopy.

[10]  D. Shum,et al.  Crystal-suppressive modulators of separated urinary polyanions , 1995 .

[11]  E. Liong,et al.  Glycosaminoglycan control of oxalate transport across cultured renal cells , 1995 .

[12]  M. Resnick,et al.  Summary of the National Institutes of Arthritis, Diabetes, Digestive and Kidney Diseases conference on urolithiasis: state of the art and future research needs. , 1995, The Journal of urology.

[13]  S. Ebisuno,et al.  Adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells and some effects of glycosaminoglycans or cell injuries. , 1995, European urology.

[14]  D. Kok,et al.  Calcium oxalate nephrolithiasis, a free or fixed particle disease. , 1994, Kidney international.

[15]  T. Nakamura,et al.  Analysis of glycosaminoglycans by high-performance liquid chromatography. , 1994, Journal of biochemical and biophysical methods.

[16]  R. Ryall,et al.  Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine. , 1994, Scanning microscopy.

[17]  F. Schröder,et al.  Etiology of experimental calcium oxalate monohydrate nephrolithiasis in rats. , 1994, Scanning microscopy.

[18]  F. Schröder,et al.  A review of new concepts in renal stone research. , 1993, Scanning microscopy.

[19]  J. Lieske,et al.  Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. , 1993, The American journal of physiology.

[20]  P. Varalakshmi,et al.  Effect of sodium pentosan polysulphate on tissue lipids in control and glycollate treated rats. , 1993, Pharmacological research.

[21]  F. Schröder,et al.  An ultrastructural study of experimentally induced microliths in rat proximal and distal tubules. , 1993, The Journal of urology.

[22]  P. Varalakshmi,et al.  Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate. , 1993, Biochemistry and molecular biology international.

[23]  T. Alkībay,et al.  Urinary glycosaminoglycan excretion following extracorporeal shock wave lithotripsy. , 1993, International urology and nephrology.

[24]  W. Foye.  Sulfur Compounds in Therapy: Radiation-Protective Agents, Amphetamines, and Mucopolysaccharide Sulfation , 1992, The Annals of pharmacotherapy.

[25]  G. Gambaro,et al.  Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. , 1992, Kidney international.

[26]  F. Schröder,et al.  The effect of two new semi-synthetic glycosaminoglycans (G871, G872) on the zeta potential of calcium oxalate crystals and on growth and agglomeration. , 1992, The Journal of urology.

[27]  J. Lieske,et al.  Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. , 1992, The American journal of physiology.

[28]  H. Koul,et al.  Clinical review 32: Calcium oxalate nephrolithiasis. , 1992, The Journal of clinical endocrinology and metabolism.

[29]  G. Gambaro,et al.  Idiopathic calcium oxalate nephrolithiasis: a cellular disease. , 1992, Scanning microscopy.

[30]  R. Baskar,et al.  Biochemical changes in kidneys of normal and stone forming rats with sodium pentosan polysulphate. , 1992, Biochemistry international.

[31]  J. Zanchetta,et al.  Glycosaminoglycans in urolithiasis. , 1992, Nephron.

[32]  Saeed R. Khan,et al.  Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. , 1992, The Journal of urology.

[33]  A. Trinchieri,et al.  Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones. , 1992, Scandinavian journal of urology and nephrology.

[34]  D. Lane,et al.  Heparin and Related Polysaccharides , 1992, Advances in Experimental Medicine and Biology.

[35]  G. Gambaro,et al.  Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans , 1991, The Lancet.

[36]  A. Borsatti,et al.  Calcium oxalate nephrolithiasis: defective oxalate transport. , 1991, Kidney international.

[37]  M. Sporn,et al.  Cytokines in context , 1991, The Journal of cell biology.

[38]  A. Hesse,et al.  Significance of glycosaminoglycans for the formation of calcium oxalate stones. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  K. Berg,et al.  Acute changes in kidney function following extracorporeal shock wave lithotripsy for renal stones. , 1991, British journal of urology.

[40]  T. Fukatani.  [Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects]. , 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[41]  S. Mulholland,et al.  The production of antibodies to pentosanpolysulfate (ELMIRON, SP-54). , 1991, Journal of immunological methods.

[42]  K. Berg,et al.  Do extracorporeal shock waves affect urinary excretion of glycosaminoglycans? , 1991, British journal of urology.

[43]  T. Esen,et al.  Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations. , 1991, European urology.

[44]  A. Al-Hakim,et al.  Electrophoresis and detection of nanogram quantities of exogenous and endogenous glycosaminoglycans in biological fluids. , 1991, Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society.

[45]  A. C. Buck,et al.  Renal Tract Stone: Metabolic Basis and Clinical Practice , 1990 .

[46]  C. Dimopoulos,et al.  Effect of drugs on crystal adhesion to injured urothelium. , 1990, Urology.

[47]  G. Gambaro,et al.  Glycosaminoglycan content, oxalate self-exchange and protein phosphorylation in erythrocytes of patients with 'idiopathic' calcium oxalate nephrolithiasis. , 1990, Clinical science.

[48]  P. Kongtawelert,et al.  A monoclonal antibody that recognizes 2,3-, 2,6-, and 4,6-disulphate ester ring substitution in pyranose-containing polysaccharides. Its production, characterization and application for the quantitation of pentosan polysulphate, dextran sulphate, glycosaminoglycan polysulphate and chondroitin sulpha , 1990, Journal of immunological methods.

[49]  D. Kok,et al.  Crystal agglomeration is a major element in calcium oxalate urinary stone formation. , 1990, Kidney international.

[50]  R. Hurst,et al.  Bladder surface glycosaminoglycans: an epithelial permeability barrier. , 1990, The Journal of urology.

[51]  Y. M. Michelacci,et al.  Urinary excretion of glycosaminoglycans in normal and stone forming subjects. , 1989, Kidney international.

[52]  K. Miyazawa,et al.  [The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone]. , 1989, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[53]  B. Casu,et al.  Structure of Heparin and Heparin Fragments , 1989, Annals of the New York Academy of Sciences.

[54]  J. Garside,et al.  The effect of glycosaminoglycans on the crystallisation of calcium oxalate. , 1989, British journal of urology.

[55]  G. Gambaro,et al.  High urinary excretion of glycosaminoglycans: a possible marker of glomerular involvement in diabetes. , 1989, Metabolism: clinical and experimental.

[56]  S. Ljunghall,et al.  Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[57]  H. E. Williams,et al.  Oxalate synthesis, transport and the hyperoxaluric syndromes. , 1989, The Journal of urology.

[58]  B. Fellström,et al.  Glycosaminoglycans as Inhibitors of Renal Stone Formation , 1989 .

[59]  F. Ofosu,et al.  Heparin and related polysaccharides. Structure and activities. , 1989, Annals of the New York Academy of Sciences.

[60]  C. Genestar,et al.  Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects. , 1989, Nephron.

[61]  A. Hemal,et al.  Comparative study of 24-hour urinary excretion of glycosaminoglycans by renal stone formers and healthy adults. , 1989, European urology.

[62]  M. Nikkilä,et al.  Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers. , 1989, Urologia internationalis.

[63]  D. Kok,et al.  Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. , 1988, Kidney international.

[64]  G. Preminger,et al.  Urinary glycosaminoglycans in normal subjects and patients with stones. , 1988, The Journal of urology.

[65]  U. Björklund,et al.  Pentosan polysulphate (Elmiron): pharmacokinetics and effects on the urinary inhibition of crystal growth , 1987 .

[66]  Sallis Jd.  Glycosaminoglycans as inhibitors of stone formation. , 1987 .

[67]  D. Kok,et al.  Polysaccharide from coccoliths (CaCO3 biomineral). Influence on crystallization of calcium oxalate monohydrate. , 1986, European journal of biochemistry.

[68]  A. Hesse,et al.  The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons. , 1986, Urologia internationalis.

[69]  S. Ljunghall,et al.  Binding of glycosaminoglycans to sodium urate and uric acid crystals. , 1986, Clinical science.

[70]  D. Kok,et al.  EXCESSIVE CRYSTAL AGGLOMERATION WITH LOW CITRATE EXCRETION IN RECURRENT STONE-FORMERS , 1986, The Lancet.

[71]  C. Parsons,et al.  Inhibition of sodium urate crystal adherence to bladder surface by polysaccharide. , 1985, The Journal of urology.

[72]  H. Iwata,et al.  Matrix glycosaminoglycan in urinary stones. , 1985, The Journal of urology.

[73]  M. Peacock,et al.  Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers. , 1984, British journal of urology.

[74]  L. Smith,et al.  Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth. , 1984, The Journal of urology.

[75]  D. Shum,et al.  A micropuncture and renal clearance study in the rat of the urinary excretion of heparin, chondroitin sulphate and metabolic breakdown products of connective tissue proteoglycans. , 1984, Clinical science.

[76]  G. Gambaro,et al.  RAISED TRANSMEMBRANE OXALATE FLUX IN RED BLOOD CELLS IN IDIOPATHIC CALCIUM OXALATE NEPHROLITHIASIS , 1984, The Lancet.

[77]  L. Kjellén,et al.  Cell-Surface Glycosaminoglycans , 1984 .

[78]  T. Fujioka,et al.  [Observation on urinary glycosaminoglycan excretion in patients with urinary calculus in relation to the nature of organic matrix of calculi]. , 1983, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[79]  N. Malavolta,et al.  Preliminary results of glycosminoglycans excretion in normal and stone forming subjects: relationship with uric acid excretion. , 1983, The Journal of urology.

[80]  W. Gill,et al.  Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. , 1982, The Journal of urology.

[81]  C. Samuell.  A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[82]  R. Ryall,et al.  The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[83]  R. Hautmann,et al.  Intrarenal Calcium and Oxalate Concentration Gradients in Healthy and Stone Forming Kidneys — The Renal Papilla as the Primary Nucleation Site , 1981 .

[84]  B. Finlayson,et al.  Urolithiasis, clinical and basic research , 1981 .

[85]  R. Bowyer,et al.  Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[86]  R. Hurst,et al.  Thermodynamics of mucopolysaccharide–dye binding. III. Thermodynamic and cooperativity parameters of acridine orange–heparin system , 1979 .

[87]  M. Peacock,et al.  Risk factors in calcium stone disease of the urinary tract. , 1978, British journal of urology.

[88]  G. Phillips,et al.  Interaction of Sulfated Polysaccharides with Counter-Ions , 1978 .

[89]  B. Finlayson,et al.  The expectation of free and fixed particles in urinary stone disease. , 1978, Investigative urology.

[90]  H. Fleisch,et al.  Disaggregation of hydroxyapatite crystals , 1976 .

[91]  Atuk No.  Letter: Intravenous aminophylline. , 1974 .

[92]  M. Peacock,et al.  Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[93]  A. Hodgkinson,et al.  Oxalic acid, calcium, and phosphorus in the renal papilla of normal and stone forming rats. , 1972, Investigative urology.

[94]  A. Butt.  Role of protective urinary colloids in prevention of renal lithiasis. , 1952, The Journal of urology.